<< Read Full Article
<< Read Full Article
Lilly Swings to Loss on ImClone Costs
- Loading Comments...
Updated from 7:24 a.m. EST
Eli Lilly(LLY Quote) swung to net loss in the fourth quarter from a year-earlier profit primarily because of costs related to the acquisition of ImClone Systems.
The Indianapolis-based drug maker said the fourth-quarter loss totaled $3.62 billion, or $3.31 a share, compared with net income of $854.4 million, or 78 cents a share, in the year-earlier quarter.
Lilly recorded a pretax charge of $4.73 billion in the fourth quarter related to the $6.5 billion purchase of the biotech firm ImClone. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |


Connect with TheStreet